Furthermore, the concurrent use of ivabradine HCl and trimetazidine decreased TGF-β1 and COL-L levels, resulting in decreased myocardial fibrosis (79) (Table 1). The gene discussed is TGFB1; the disease is Myocardial fibrosis.